510(k) K210017 ยท PZM Next Generation Sequencing Based Tumor Profiling Test
ACTOnco, ACTOnco IVD
| Applicant | Act Genomics, Taipei, TW |
| Decision | Substantially Equivalent, Dec 23, 2022 |
| Received | Jan 4, 2021 |
| Type | Traditional |
| FDA record | Open on fda.gov |
Recalls that name K210017
No recall in the FDA data names this 510(k).
Links come from the 510(k) numbers listed on each FDA recall record. We don't infer predicate chains.